Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
公司代碼HBIO
公司名稱Harvard Bioscience Inc
上市日期Oct 21, 2013
CEODuke (John D)
員工數量330
證券類型Ordinary Share
年結日Oct 21
公司地址84 October Hill Rd
城市HOLLISTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01746-1371
電話15088938999
網址https://www.harvardbioscience.com/
公司代碼HBIO
上市日期Oct 21, 2013
CEODuke (John D)